Press release
Modern Healthcare Honors Dr. Peter Pronovost as a Top 25 Innovator for Spearheading Remote Monitoring Program at University Hospitals Using Masimo’s Technology
IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced that Peter J. Pronovost, MD, PhD, Chief Quality and Clinical Transformation Officer
About this update from Masimo Corporation
[{"type":"text","content":"\n \n\n IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo (NASDAQ: MASI) today announced that Peter J. Pronovost, MD, PhD, Chief Quality and Clinical Transformation Officer at University Hospitals in Cleveland (UH), has been named a “Top 25 Innovator” by Modern Healthcare for his contribution to University Hospitals’ launch of the Masimo SafetyNet™ remote patient management solution for people who tested positive for COVID-19.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200902005819/en/Dr. Peter Pronovost with Masimo SafetyNet™ (Photo: Business Wire)\n\nLong recognized throughout the industry for his expertise and innovation in patient safety and quality of care, Pronovost led a team earlier this year to pilot Masimo SafetyNet, a secure telehealth solution that combines tetherless Masimo SET® pulse oximetry with a remote patient surveillance platform programmed with a COVID-19 care protocol. “Masimo SafetyNet was transformational in helping us respond to the pandemic by providing UH an innovative, high-value way to help us prepare for a potential surge in patient volume,” said Pronovost.\n\n\nSince its initial deployment in March, Masimo SafetyNet has expanded to allow continuous temperature measurement using the tetherless Radius Tº™ sensor. Masimo SafetyNet is now in use at more than 130 institutions around the world.\n\n\nJoe Kiani, Founder and CEO of Masimo, commented, “Dr. Pronovost, with his pioneering work on Masimo SafetyNet, has helped pave the way to save the lives of COVID-19 patients—a testament to his vision and dedication. On behalf of the many thousands who have benefited and who will benefit from his passion and brilliance over the span of his career, I am thrilled to congratulate him on this well-deserved honor. His values align closely with Masimo’s commitment to improving patient outcomes and reducing the cost of care.”\n\n\n@MasimoInnovates | #Masimo\n\n\nAbout Masimo\n\n\nMasimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve patient outcomes and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oxi...